Urinary stone disease is a significant health problem in the United States, with an estimated cost of $2 billion (based on 2003 dollars) per year.1 Although surgical management has become increasingly tolerable, medical prevention of recurrent calculi is feasible, easily obtained, and greatly desirable.
|Physicians should advise patients to increase their water intake to reduce the risk of recurrence of urinary calculi and to prolong the average interval of recurrence.
|Findings from one prospective trial and usual clinical practice
|Physicians should advise patients to limit their intake of sodium and animal protein to reduce the risk of developing urinary calculi.
|Supported by prospective trials and large population studies
|Potassium citrate (Urocit-K) should be administered to decrease the risk of developing calcium oxalate stones.
|Findings from one randomized trial and usual clinical practice
The prevalence of urinary calculi is estimated to be 5 percent in the general population, with an annual incidence of as much as 1 percent.2 Men are twice as likely as women to develop calculi, with the first episode occurring at an average age of 30 years.3 Women have a bimodal age of onset, with episodes peaking at 35 and 55 years. Without preventive treatment, the recurrence rate of calcium oxalate calculi increases with time and reaches 50 percent at 10 years.3
Renal calculi are crystalline mineral deposits that form in the kidney. They develop from microscopic crystals in the loop of Henle, the distal tubule, or the collecting duct, and they can enlarge to form visible fragments.3 The process of stone formation depends on urinary volume; concentrations of calcium, phosphate, oxalate, sodium, and uric acid ions; concentrations of natural calculus inhibitors (e.g., citrate, magnesium, Tamm-Horsfall mucoproteins, bikunin); and urinary pH.4 High ion levels, low urinary volume, low pH, and low citrate levels favor calculus formation. Risk factors and their mechanisms of action are listed in Table 1.
|Promotes low urine volume; acidic urine depletes available citrate; hyperoxaluria
|Excess dietary meat (including poultry)
|Creates acidic urinary milieu, depletes available citrate; promotes hyperuricosuria
|Excess dietary oxalate
|Excess dietary sodium
|Ammonia mishandling; alters pH of urine
|Low urine volume
|Allows stone constituents to supersaturate
|May promote hypercalciuria; other results similar to excess dietary meat
|Creates persistent hypercalciuria
|Bone turnover creates hypercalciuria
|Renal tubular acidosis (type 1)
|Alkaline urine promotes calcium phosphate supersaturation; loss of citrate
Calculi are classified into five categories based on their composition: calcium oxalate (70 percent), calcium phosphate (5 to 10 percent), uric acid (10 percent), struvite (15 to 20 percent) and cystine (1 percent).3 Calculi can be classified more broadly into calcareous (i.e., calcium-containing) stones and noncalcareous stones. Calcareous stones usually are visible on radiographic imaging (Figure 1), whereas noncalcareous stones (i.e., uric acid, cystine, struvite calculi) often are radiolucent or poorly visualized on plain film radiography. Many calculi have a mixed composition, with one type of crystal becoming a nidus for heterogeneous crystallization.
Acute Episodes: Diagnosis and Treatment
Most renal calculi do not cause significant symptoms until the stones begin to travel within the urinary tract. At this point, the pain of acute renal colic is severe and can be debilitating. Patients commonly describe the pain as crampy and intermittent. It usually originates in the flank and radiates toward the groin. Because calculus movement is associated with obstruction of a hollow viscus, many patients suffer from associated nausea, with or without emesis. Most patients have at least microscopic amounts of blood in the urine, and gross hematuria is possible. Patients with obstructing struvite calculi (i.e., stones associated with urinary infection) may present with fevers, chills, and flank pain. These patients are at risk of progressing to sepsis or death.
Not all patients presenting with f lank pain have urinary calculi, so an important aspect of the initial evaluation is to search for other potential diagnoses (Table 2). A typical work-up includes a thorough history and physical examination, serum chemistry and complete blood count, urinalysis, and an imaging study. Typical radiographic and laboratory findings are presented in Table 3.
|Anorexia, nausea, vomiting
|Obstructing urinary calculi, bowel disease
|UTI, urinary calculi, interstitial cystitis
|Viral or bacterial illness
|Hematuria (microscopic or gross)
|Urinary calculi, urothelial tumor, UTI, BPH, renal mass
|Nonspecific findings of shock (including possible sepsis)
|Inability to get comfortable
|Urinary calculi, peritonitis
|Pain and tenderness
|Small renal calculi, nonurologic etiology (gastrointestinal origin)
|Flank pain (sharp, extreme pain with sudden onset)
|Urinary calculi, musculoskeletal spasm
|Urinary calculi, musculoskeletal inflammation, pyelonephritis
|Groin pain (scrotal, labial)
|Ureteral calculi, hernia, testicular mass
|Penile or pelvic pain
|Ureteral calculi, urethritis, prostatitis
|UTI, interstitial cystitis, prostatitis, urinary calculi, peritonitis
|Nonspecific response to pain
|UTI, ureteral calculi, BPH
|Complete blood count
|Leukocytosis with struvite calculi
|Elevation in creatinine levels with obstructing calculi; hypokalemia and hyperchloremia with renal tubular acidosis; elevated serum calcium levels with parathyroid disease
|Serum parathyroid hormone levels
|Elevated in hyperparathyroidism
|Microscopic or gross hematuria; acidic urine; alkaline urine (with struvite calculi); pyuria; crystals from involved calculi
|Elevated urinary calcium, oxalate, and sodium levels; decreased urinary volume and citrate levels
|Abdominal, kidney, and upper bladder radiography
|Urinary calculi larger than 2 mm may be visible.
|CT (stone protocol)
|Nearly all calculi are visible on CT. Evaluates renal parenchyma, hydronephrotic changes, and surrounding organs for other etiologies of abdominal pain.
|Calculi visible on scout film. Delay in contrast excretion if obstruction is present. Calculi may appear as filling defect.
|Conventional MRI is not useful for imaging calculi.
|Calculi appear as hyperechoic lesions that cast acoustic shadows. Not reliable for ureteral calculi. May demonstrate dilation of collecting system.
Most calculi are visible on plain film radiography, but noncontrast computed tomography (CT) has become the imaging modality of choice because of its ability to visualize stones of any composition (Figure 2), its ability to identify unexpected concomitant pathology, and the absence of intravenous contrast media.5,6 Stone size can be measured from most imaging modalities, providing prognostic information.
With hydration and pain control, calculi smaller than 5 mm will pass spontaneously in approximately 90 percent of patients. The rates of passage decrease as stone size increases; a 1-cm stone has a less than 10 percent chance of passing without surgical intervention.7 Recent studies8 have suggested that the use of the alpha1-adrenergic blocker tamsulosin (Flomax) can increase the chance of spontaneous passage of ureteral stones. However, immediate surgical intervention with a ureteral stent or percutaneous nephrostomy is necessary if the patient exhibits signs and symptoms of obstruction and sepsis. Clinically stable patients usually are given the option of attempting to pass the stone spontaneously if it is not too large and if the pain is manageable with oral narcotics. Surgical options include extracorporeal shock wave lithotripsy, ureteroscopic stone extraction, and percutaneous nephrolithotomy.
Stone Recurrence: Prevention and Treatment
After the initial stone episode has resolved, patients should be counseled about prevention of recurrences. A basic evaluation should include a thorough history, including age at onset, frequency and number of previous calculi, and any previous medical or surgical interventions. Additional information should include an evaluation of fluid and dietary habits and a history of predisposing conditions such as bowel disease, gout, and a family history of urinary calculi. Serum studies should include electrolyte, calcium, phosphate, uric acid, and intact parathyroid hormone levels.
A more thorough evaluation has been advocated for patients who have had more than one stone episode. In these patients, the expense of additional laboratory tests and pharmacotherapy likely is less than the expense of repeat emergency department visits and surgical management.9,10 An expanded evaluation includes two 24-hour urine collections to determine urine volume, pH, and calcium, creatinine, sodium, phosphate, oxalate, citrate, uric acid, and cystine levels. Crystallographic analysis of retrieved calculus remnants can help identify the underlying etiology and may obviate a complete metabolic evaluation.
Medical prophylaxis of recurrent urinary calculi includes generalized recommendations and specific directed therapy when appropriate (Figure 3). As noted previously, patients with recurrent episodes warrant a more aggressive approach.
Evidence from one prospective trial11 indicates that increased water intake reduces the risk of recurrence of urinary calculi and prolongs the average interval between recurrences. A target of 2.1 qt (2 L) of urine production per day generally is recommended.12 One prospective study13 showed that a low-salt, low-meat, moderate-calcium diet is more effective at limiting stone recurrence than a low-calcium diet. The presence of calcium in the gut helps bind oxalate from foods, thereby limiting the absorption of oxalate in the large intestine. Avoidance of large quantities of high–oxalate-containing foods is recommended. Obesity is an independent risk factor for urinary calculi, particularly in women.14,15 Weight loss is desirable in these patients.
CALCIUM OXALATE CALCULI
Calcium oxalate stones are the most common type of urinary calculi and can exist in monohydrate and dihydrate forms, with or without phosphate. High phosphate content may be associated with higher recurrence rates.16 Calcium oxalate stones are radiopaque and usually visible on plain film radiography or noncontrast CT.
The causes of calcium oxalate stones and their mechanisms are listed in Table 4. Hypercalciuria (i.e., more than 250 mg per 24 hours [6.2 mmol per day]) is the most common metabolic abnormality associated with these calculi, followed by hypocitraturia (i.e., less than 450 mg per 24 hours [2.34 mmol per day]), which involves a deficiency of the naturally occurring stone inhibitor citrate. The cause of hypocitraturia often is idiopathic, although high dietary acid loads (e.g., from excessive meat intake) and dehydration can exacerbate this condition. Other causes of calcium oxalate stones include hyperoxaluria (i.e., more than 45 mg per 24 hours [500 μmol per day]) and hyperuricosuria (i.e., more than 800 mg per 24 hours [4.76 mmol per day]). Treatments for these stones depend on the underlying condition (Table 4). Note that there are no specific medications for hyperoxaluria; medical treatment consists of increasing calcium intake (particularly with meals) to control enteric hyperoxaluria. Additionally, decreasing the intake of oxalates contained in foods such as spinach, rhubarb, beets, chocolate, nuts, tea, strawberries, soy foods, and wheat bran may be beneficial.17 Calcium oxalate calculi not associated with an obvious laboratory abnormality can be treated empirically with oral potassium citrate (Urocit-K, 30 to 60 mEq per day) or sodium citrate (Bicitra) to increase urine pH and levels of urinary citrate.18,19
|Hypercalciuria (more than 250 mg per 24 hours [6.2 mmol per day])
|Increased intestinal absorption of calcium
|Thiazide diuretic*, potassium citrate (Urocit-K)†
|Thiazide diuretic*, potassium citrate†
|Increased bone demineralization or increased intestinal calcium absorption
|Renal leak of calcium
|Thiazide diuretic*, potassium citrate†
|Hyperoxaluria (more than 45 mg per 24 hours [500 μmol per day])
|Malabsorption from any cause with increased urinary oxalate to complex with calcium
|Decrease oxalate intake, increase calcium intake
|Metabolic error with high level of oxalate production and urinary excretion
|Decrease oxalate intake, increase calcium intake
|Hyperuricosuria (more than 800 mg per 24 hours [4.76 mmol per day])
|Increased uric acid promotes calcium oxalate crystallization via the formation of nuclei
|Potassium citrate†, allopurinol (Zyloprim; 100 to 300 mg daily, given orally)
|Hypocitraturia (less than 450 mg per 24 hours [2.34 mmol per day])
|Idiopathic; renal tubular acidosis (types 1, 2, and 4)
CALCIUM PHOSPHATE CALCULI
Calculi that consist predominantly of calcium phosphate occur more often in women than in men. They often are associated with acidification disorders such as renal tubular acidosis20; less common etiologies include primary hyperparathyroidism, excessive alkalinization, and sarcoidosis. Renal tubular acidosis is associated with hypercalciuria and hypocitraturia. Medical treatment of these stones consists of replenishing urinary citrate to prevent new stone formation and delay growth of existing stones. Care must be taken to avoid excessive alkalinization, because high urinary pH can increase the urinary supersaturation of calcium phosphate salts. If hypercalciuria persists, addition of a thiazide diuretic is indicated.21
URIC ACID CALCULI
Uric acid stones may consist of uric acid only, or they also may contain calcium.22 Uric acid is a by-product of ingested or endogenous purine metabolism and is excreted in the urine primarily in insoluble form. The primary cause of uric acid stones is a urinary pH below the pKa for uric acid (5.5). Other predisposing conditions include gout, insulin-resistant states, and end-ileostomies. Men with gout have a twofold risk of having a uric acid calculus.23 In general, these patients excrete excessive uric acid (although some have normouricosuria) and have low urinary pH and urine volumes. Excess ingestion of animal meat protein (i.e., meat of all types, including poultry) can be detected by measuring urinary sulfate levels. Radiographic imaging can be difficult because pure uric acid calculi typically are radiolucent. They are, however, readily apparent on noncontrast CT. In addition to the general measures outlined above, treatment of uric acid stones involves correction of urinary pH. Potassium citrate at a dosage of 30 to 60 mEq per day will raise the urinary pH to greater than 5.5 (6.5 to 7 is ideal).24 Allopurinol (Zyloprim) at a dosage of 300 mg daily can be added in patients with hyperuricemia.
Struvite stones, also known as infection or triple-phosphate stones, consist of magnesium, ammonium, and calcium phosphate. They occur more often in women than in men and are the leading cause of staghorn calculi (Figure 4). Neurogenic bladders and foreign bodies in the urinary tract also predispose patients to struvite calculi. Recurrent urinary tract infections with urea-splitting organisms (e.g., Proteus mirabilis, Urea-plasma urealyticum, Klebsiella pneumoniae) result in alkalinization of urine and the addition of ammonium to the milieu.25 Struvite stones are usually radiopaque on standard radiographic imaging but may be quite faint. Patients with struvite calculi may present with flank pain and may have signs of systemic infection.
There is good evidence that failure to treat struvite stones can lead to an increased risk of renal loss, sepsis, and death.26,27 However, if the patient is febrile or presents with signs of systemic infection, surgical manipulation should be delayed until antibiotic treatment has been administered and the patient has been afebrile for at least 48 hours. After surgical intervention, medical therapy should focus on preventing recurrent urinary tract infections. Retained residual fragments increase the risk of recurrent urinary tract infection and future calculi. Acetohydroxamic acid (Lithostat) is an irreversible inhibitor of urease and can prevent the crystallization of struvite stones.28 However, because of side effects (including deep venous thrombosis), it generally is reserved for use in patients who cannot tolerate surgical intervention.29
Patients with cystine calculi have an autosomal recessive disorder of dibasic amino acid transport leading to decreased cystine resorption in the kidney. Only homozygote patients form cystine calculi and often present with stones during childhood. Calculi may be pure cystine or may be mixed with calcium oxalate. Cystine is poorly soluble at normal urinary pH and will readily form stones when levels rise above a concentration of 250 mg per L. Pure cystine stones are yellow and radiolucent or faintly radiopaque (Figure 5). A urinary cystine level of more than 250 mg per 24 hours (1,040 μmol per day) is diagnostic for the disorder
Dietary manipulation with a low-methionine diet is difficult and rarely successful. Hydration and administration of urinary alkalinizing agents such as potassium citrate are mainstays of therapy. However, it often is difficult to achieve adequate alkalinization with oral agents. If these measures are not effective, administration of cystine binders such as penicillamine (Cuprimine) and tiopronin (Thiola) can help prevent cystine calculi. Although these agents are effective, they can cause significant side effects such as gastrointestinal distress, rheumatologic symptoms, mental status changes, and skin rashes.30